3D Bioprinting of cardiac tissue and cardiac stem cell therapy
Open accessThe DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Abstract
Cardiovascular tissue engineering endeavors to repair or regenerate damaged or ineffective blood vessels, heart valves, and cardiac muscle. Current strategies that aim to accomplish such a feat include the differentiation of multipotent or pluripotent stem cells on appropriately designed biomaterial scaffolds that promote the development of mature and functional cardiac tissue. The advent of additive manufacturing 3D bioprinting technology further advances the field by allowing heterogenous cell types, biomaterials, and signaling factors to be deposited in precisely organized geometries similar to those found in their native counterparts. Bioprinting techniques to fabricate cardiac tissue in vitro include extrusion, inkjet, laser-assisted, and stereolithography with bioinks that are either synthetic or naturally-derived. The article further discusses the current practices for post-fabrication conditioning of 3D engineered constructs for effective tissue development and stability, then concludes with prospective points of interest for engineering cardiac tissues in vitro. Cardiovascular three-dimensional bioprinting has the potential to be translated into the clinical setting and can further serve to model and understand biological principles that are at the root of cardiovascular disease in the laboratory.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alginate: Properties and biomedical applications
Lee, K. Y., & Mooney, D. J. (2012) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2011.06.003 · Cited by 8,095 · cited 2×
“used the inkjet printing technique to develop a hierarchical design of functional cardiac pseudo tissues with a beating cell response, balanced by porosity for mass and structural support [88].”
BackgroundMethodHydrogels for Tissue Engineering
Lee, K. Y., & Mooney, D. J. (2001) · Chemical Reviews · doi:10.1021/cr000108x · Cited by 5,277
Hydrogels for tissue engineering: scaffold design variables and applications
Drury, J. L., & Mooney, D. J. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00340-5 · Cited by 5,136
Inkjet Printing—Process and Its Applications
Singh, M., Haverinen, H. M., Dhagat, P., & Jabbour, G. E. (2010) · Advanced Materials · doi:10.1002/adma.200901141 · Cited by 2,375 · cited 1×
“Inkjet printers can generate high resolution structures (20–100 μm) at the deposition rate of 1–1000 drops/s [56].”
Background3D bioprinting of vascularized, heterogeneous cell-laden tissue constructs
Kolesky, D. B., Truby, R. L., Gladman, A. S., Busbee, T. A., Homan, K. A., & Lewis, J. A. (2014) · Advanced Materials · doi:10.1002/adma.201305506 · Cited by 2,102 · cited 1×
“To this end, two alternative approaches have been considered: (i) indirect bioprinting by utilizing a fugitive ink that is removed by thermally induced decrosslinking, leaving a vascular network behind [137]; and (ii) direct bioprinting of a vasculature network in a tubular shape [138].”
MethodPrinting three-dimensional tissue analogues with decellularized extracellular matrix bioink
Pati, F., Jang, J., Ha, D.-H., Won Kim, S., Rhie, J.-W., Shim, J.-H., Kim, D.-H., & Cho, D.-W. (2014) · Nature Communications · doi:10.1038/ncomms4935 · Cited by 1,904 · cited 9×
“Moreover, studies have also shown that decellularized ECM can fabricate biological scaffolds as a bio-ink to supply biochemical cues more effectively compared to a polymer-based bioink for 3D printing [22, 128].”
BackgroundInfluentialHinton, T. J., Jallerat, Q., Palchesko, R. N., Park, J. H., Grodzicki, M. S., Shue, H.-J., Ramadan, M. H., Hudson, A. R., & Feinberg, A. W. (2015) · Science Advances · doi:10.1126/sciadv.1500758 · Cited by 1,805 · cited 1×
“To this end, two alternative approaches have been considered: (i) indirect bioprinting by utilizing a fugitive ink that is removed by thermally induced decrosslinking, leaving a vascular network behind [137]; and (ii) direct bioprinting of a vasculature network in a tubular shape [138].”
MethodPatra, P. P., Chikkaraddy, R., Tripathi, R. P. N., Dasgupta, A., & Kumar, G. V. P. (2014) · Nature Communications · doi:10.1038/ncomms5357 · Cited by 1,635
Design properties of hydrogel tissue-engineering scaffolds
Zhu, J., & Marchant, R. E. (2011) · Expert Review of Medical Devices · doi:10.1586/erd.11.27 · Cited by 1,430 · cited 1×
“The biomaterials of choice usually involve either natural or synthetic hydrogels, or decellularized matrices as they provide a porous, interconnected polymeric network that allow cells to migrate, proliferate, and receive the nutrients that are essential to their survival [12].”
BackgroundX-ray-Computed Tomography Contrast Agents
Lusic, H., & Grinstaff, M. W. (2013) · Chemical Reviews · doi:10.1021/cr200358s · Cited by 1,108 · cited 1×
“On the contrary, CMR can obtain high-resolution images without ionizing radiation, and can discern the tissue composition without the iodinated contrast media [33].”
Background
Cited by
Cardiac Tissues From Stem Cells: New Routes to Maturation and Cardiac Regeneration
Campostrini, G., Windt, L. M., van Meer, B. J., Bellin, M., & Mummery, C. L. (2021) · Circulation Research · doi:10.1161/circresaha.121.318183 · Cited by 96
Synthetic scaffolds for 3D cell cultures and organoids: applications in regenerative medicine
Marchini, A., & Gelain, F. (2022) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2021.1932716 · Cited by 91
“patches with heart-like structures [122].”
Fang, Y., Sun, W., Zhang, T., & Xiong, Z. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2021.121298 · Cited by 40
Engineered stem cells by emerging biomedical stratagems
Wang, J., Zhang, X., Chen, H., Ren, H., Zhou, M., & Zhao, Y. (2024) · Science Bulletin · doi:10.1016/j.scib.2023.12.006 · Cited by 37
Metadata
- Authors
- Alonzo, M., AnilKumar, S., Roman, B., Tasnim, N., & Joddar, B.
- Venue
- Translational Research
- Publisher
- Elsevier BV
- Published
- 2019-09
- Volume
- 211
- Pages
- 64-83
- ISSN
- 1878-1810 (ISSN-L)
- 1931-5244
- OpenAlex
- W2936458746
- Cited by
- 159
- References
- 133
- FWCI
- 5.56
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.